Synonyms | HMS3402K12 l-Prostaglandin E2 Prostaglandin,PGE2 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid NCGC00092361-02
RP17686 alpha, Prostaglandin E2 NSC-196514 SR-05000001459-4 BRD-K26521938-001-04-9 Prepidil XEYBRNLFEZDVAW-ARSRFYASSA-N Cerviprime (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid DB00917 (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate Dinoprostone [USAN:INN:BAN:JAN] (E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid DSSTox_RID_76801 1798-EP2277858A1 Gel, Prepidil Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)- 1798-EP2311453A1 1798-EP2314574A1 IDI1_033960 Prostaglandin E2, >=93% (HPLC), synthetic 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)- MFCD00077861 Prostenone AC-6098 NCGC00092361-05 SR-01000946417 BC219642 P1884 U 12062 CAS-363-24-6 [3H]dinoprostone CHEMBL548 (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic Dinoprostona [INN-Spanish] (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid Dinoprostone, United States Pharmacopeia (USP) Reference Standard (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid E2, Prostaglandin Prepidil Gel 1798-EP2301922A1 HMS1361K12 Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)- HMS2089D17 Prostaglandin E l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid Prostaglandin E2.alpha. 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l- MolPort-003-939-184 Prostin E2 AKOS015920228 NSC 196514 SR-05000001459-1 BMS-279654 & PGE2 PGE2 alpha U-12062 Cervidil (-)-Prostaglandin E2 [3H]prostin E2 D06FEA (5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid Dinoprostone beta-Cyclodextrin Clathrate (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid DSSTox_CID_2947 1798-EP2272832A1 Enzaprost E Propess (TN) 1798-EP2308510A1 1798-EP2311808A1 HMS3648F07 Prostaglandin E2 alpha 363-24-6 LMFA03010003 Prostarmon E 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid NCGC00092361-03 SCHEMBL25533 AN-10387 NSC165560 Tox21_111196 BSPBio_001490 ZINC3830713 CHEBI:15551 (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Dinoproston (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid Dinoprostone [USAN:USP:INN:BAN:JAN] (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid DTXSID4022947 1798-EP2295055A2 GTPL1883 Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)- 1798-EP2314587A1 J-502620 Prostaglandin E2, gamma-irradiated, powder, BioXtra, suitable for cell culture 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)- (8CI) Minprositin E2 Prostin AC1NQWXW NCGC00092361-06 SR-01000946417-1 BDBM35847 P2E U,062 CCG-208092 [3H]PGE2 CS-6932 (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Dinoprostone (5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Dinoprostonum (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid E2alpha, Prostaglandin Prestwick_793 1798-EP2305641A1 HMS1791K12 HMS3268J12 Prostaglandin E(2) l-PGE2 Prostaglandin E2alpha 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]- NCGC00092361-01 Prostin E2 (TN) alpha, PGE2 NSC-165560 SR-05000001459-3 BR-72815 PGE2alpha UNII-K7Q1JQR04M Cervidil (TN) (15S)-Prostaglandin E2 (5Z,11|A,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid Dinoprostone Prostaglandin E2 (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid DSSTox_GSID_22947 1798-EP2277848A1 EX-A1773 Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo- 1798-EP2308872A1 1798-EP2311829A1 HY-101952 Prostaglandin E2, 98% 363P246 LS-125823 Prostarmon E2 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid NCGC00092361-04 SMP2_000056 B7005 NSC196514 Tox21_111196_1 C00584 [3H]-PGE2 (5Z,11?,13E,15S)-11,15-Dihydroxy-9-oxo-prosta-5,13-dien-1oic acid Dinoprostona (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate Dinoprostone, European Pharmacopoeia (EP) Reference Standard (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid E2 alpha, Prostaglandin Prepidil (TN) 1798-EP2298767A1 GTPL1916 Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo- HMS1989K12 prosta-glandin e2 1798-EP2316829A1 K7Q1JQR04M Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI) Minprostin E2 Prostin E AJ-45765 NSC 165560 SR-05000001459 BML1-F07 PGE2 U-12,062 CCG-208256 [3H]prostaglandin E2 D00079 (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid Dinoprostone (JAN/USP/INN) (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate Dinoprostonum [INN-Latin] 05D31BD5-818B-4A92-8CFC-BEC19926A5B3 EINECS 206-656-6 Propess 1798-EP2305653A1 [ Show all ] |
---|